Clinical Trials on NK Cell Mediated Immunity in Hong Kong

Total 2 results

The University of Hong Kong
Merck Sharp & Dohme LLC

Unknown

Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas

T-Cell Lymphoma | NK-Cell Lymphoma

Hong Kong
National Cancer Institute (NCI)

Active, not recruiting

Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma

Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma | Recurrent Nasopharyngeal Undifferentiated Carcinoma | Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Adult Nasal Type Extranodal NK/T-Cell Lymphoma | Stage IV Nasopharyngeal Undifferentiated Carcinoma...

United States, Singapore, Japan, Hong Kong

3

Subscribe